← ANALYST RATINGS · TIPRANKS
BioLife Solutions (BLFS): analyst forecast and price target
Analyst consensus
Hold0 Buy7 Hold0 Sell
Ratings of 7 analysts in the last 3 months12-month forecast
Based on 7 price targets given in the last 3 months, the average target is $31.00, the highest $31.00, the lowest $31.00. The average is −19.7% from the last price of $38.61.
Analyst ratings 9
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $44.00 → $43.00−2.3% | Buy | +11.4% | Reiterated | 06.10.26on TipRanks 01:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $44.00 → $43.00−2.3% | Buy | +11.4% | Reiterated | 06.10.26on TipRanks 01:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $43.00 → $42.00−2.3% | Buy | +8.8% | Upgrade | 06.10.26on TipRanks 01:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $42.00 → $41.00−2.4% | Hold | +6.2% | Reiterated | 06.10.26on TipRanks 01:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $44.00 → $43.00−2.3% | Buy | +11.4% | Reiterated | 06.10.26on TipRanks 01:05 | — | |
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $43.00 → $44.00+2.3% | Buy | +14.0% | Reiterated | 30.09.26on TipRanks 00:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $43.00 → $44.00+2.3% | Buy | +14.0% | Reiterated | 30.09.26on TipRanks 00:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $42.00 → $43.00+2.4% | Buy | +11.4% | Upgrade | 30.09.26on TipRanks 00:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $41.00 → $42.00+2.4% | Hold | +8.8% | Reiterated | 30.09.26on TipRanks 00:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $43.00 → $44.00+2.3% | Buy | +14.0% | Reiterated | 30.09.26on TipRanks 00:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $43.00 → $44.00+2.3% | Buy | +14.0% | Reiterated | 30.09.26on TipRanks 00:05 | — | |
| Matt Hewitt★★★★★★★★★★#3011 · hits 47% · avg +4.1% | Craig-Hallum | — | Hold | — | Reiterated | 29.09.26on TipRanks Sep 30 05:45 | +0.4%next day −0.7% | ↗ |
| Thomas Flaten★★★★★★★★★★#1650 · hits 47% · avg +8.9% | Lake Street | $31.00 | Hold | −19.7% | Reiterated | 09.09.26on TipRanks 07:50 | −0.8%next day +0.6% · 5 days +4.5% | ↗ |
| Robert Wasserman★★★★★★★★★★#2200 · hits 44% · avg +9.2% | Benchmark Co. | — | Hold | — | Downgrade | 10.08.26on TipRanks 06:27 | 0.0%next day +0.8% · 5 days +2.4% | ↗ |
| Brendan Smith★★★★★★★★★★#458 · hits 56% · avg +27.3% | TD Cowen | $31.00 | Hold | −19.7% | Reiterated | 07.08.26on TipRanks 10:46 | +1.5%next day 0.0% · 5 days +0.8% | ↗ |
| Steven Etoch★★★★★★★★★★#2413 · hits 86% · avg +59.3% | Stephens | $32.00 → $31.00−3.1% | Hold | −19.7% | Downgrade | 27.07.26on TipRanks 14:10 | −0.7%next day +7.1% · 5 days +5.4% | ↗ |
| Matthew Stanton, CFA★★★★★★★★★★#10524 · hits 43% · avg −10.9% | Jefferies | $30.00 → $31.00+3.3% | Hold | −19.7% | Downgrade | 23.07.26on TipRanks Jul 24 08:10 | 0.0%next day −2.7% · 5 days +2.4% | ↗ |
| Yi Chen★★★★★★★★★★#10518 · hits 41% · avg −1.0% | H.C. Wainwright | $32.00 → $31.00−3.1% | Hold | −19.7% | Downgrade | 23.07.26on TipRanks Jul 24 08:10 | 0.0%next day −2.7% · 5 days +2.4% | ↗ |
| Jason McCarthy★★★★★★★★★★#12398 · hits 30% · avg −13.6% | Maxim Group | — | Hold | — | Downgrade | 23.07.26on TipRanks Jul 24 08:10 | 0.0%next day −2.7% · 5 days +2.4% | ↗ |
| Carl Byrnes★★★★★★★★★★#11765 · hits 37% · avg −4.0% | Northland Securities | $34.00 | Buy | −11.9% | Reiterated | 24.03.26on TipRanks 08:35 | +3.1%next day +0.3% · 5 days −2.7% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering BioLife Solutions
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $31.00 at a price of $38.85 (−20.2%); now: $31.00 at $38.61 (−19.7%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 1 | 1 | 0 | 0 | 0 |
| Buy | 6 | 8 | 6 | 3 | 0 | 0 |
| Hold | 0 | 0 | 7 | 10 | 12 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.05 (from $0.01 to $0.07). Last quarter: $0.91.
Sales
Next quarter’s sales estimate — $29M (from $29M to $30M). Last quarter: $28M.
Best top-analyst consensus in the sector · Healthcare
About BioLife Solutions
- CEO: Roderick de Greef
- Employees: 155
- 3303 Monte Villa Parkway, Bothell, WA, 98021, US
- www.biolifesolutions.com
BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.
Data from the stock’s TipRanks forecast page, read 10665 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗